Patients Who Use Natpara Say They are Suffering After Recall

The sudden recall of a drug for hypo-para-thyroidism is leaving thousands of people in limbo with few options for treating their disease. In this segment, we talk to Becky Buckman who took part in the clinical trials for Natpara and says the drug is a lifesaver. She is now part of a group of patients/activists pushing the FDA for help in re-instating the medication that is helping thousands of people with hyp-para-thyroidism.

Cristina Mendonsa

Cristina Mendonsa

Want to know more about Cristina Mendonsa? Get her official bio, and more. Read more

title

Content Goes Here